NDC Package 14335-133-01 Sodium Nitroprusside

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
14335-133-01
Package Description:
1 VIAL in 1 CARTON / 100 mL in 1 VIAL
Product Code:
Proprietary Name:
Sodium Nitroprusside
Non-Proprietary Name:
Sodium Nitroprusside
Substance Name:
Sodium Nitroprusside
Usage Information:
Diseases with compensatory hypertension (e.g., coarctation of the aorta, arteriovenous shunting). Inadequate cerebral circulation or in moribund patients (A.S.A. Class 5E) coming to emergency surgery. Patients with congenital (Leber’s) optic atrophy or with tobacco amblyopia.   Acute heart failure associated with reduced peripheral vascular resistance. Concomitant use with sildenafil, tadalafil, vardenifil, or riociguat. 
11-Digit NDC Billing Format:
14335013301
NDC to RxNorm Crosswalk:
  • RxCUI: 1876368 - sodium nitroprusside 50 MG in 100 ML Injection
  • RxCUI: 1876368 - 100 ML sodium nitroprusside 0.5 MG/ML Injection
  • RxCUI: 1876368 - sodium nitroprusside 0.5 MG/ML per 100 ML Injection
  • RxCUI: 1876368 - sodium nitroprusside 50 MG per 100 ML Injection
  • RxCUI: 1999185 - sodium nitroprusside 10 MG in 50 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hainan Poly Pharm. Co., Ltd.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA215846
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    12-31-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 14335-133-01?

    The NDC Packaged Code 14335-133-01 is assigned to a package of 1 vial in 1 carton / 100 ml in 1 vial of Sodium Nitroprusside, a human prescription drug labeled by Hainan Poly Pharm. Co., Ltd.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 14335-133 included in the NDC Directory?

    Yes, Sodium Nitroprusside with product code 14335-133 is active and included in the NDC Directory. The product was first marketed by Hainan Poly Pharm. Co., Ltd. on December 31, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 14335-133-01?

    The 11-digit format is 14335013301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-214335-133-015-4-214335-0133-01